ADH1B*2与非酒精性脂肪性肝病成人患者疾病严重程度降低相关,且不依赖于饮酒量
研究纳入4项NASH临床研究网络中1557例经活检证实的多族裔NAFLD成人患者,分析ADH1B*2与饮酒量同组织学严重程度的关系。校正混杂因素后,ADH1B*2与脂肪性肝炎(OR 0.52;P<.01)及纤维化(OR 0.69;P=.050)频率降低相关,且ADH1B*2可能修饰高BMI与NAFLD严重程度之间的关联。
要点
- ADH1B*2与脂肪性肝炎风险降低相关(OR 0.52;P<.01)。
- ADH1B*2与纤维化风险降低相关(OR 0.69;P=.050)。
- ADH1B*2可能修饰高BMI与NAFLD严重程度之间的关联。
核心结论
- ADH1B*2降低NAFLD成人患者NASH和纤维化的风险,且不依赖于饮酒状态。
- ADH1B*2可能修饰高体重指数与NAFLD严重程度之间的关联。
研究设计与样本
- 研究收集了由NASH临床研究网络开展的4项不同研究纳入的1557例经活检证实的多族裔NAFLD成人患者的数据。
- 饮酒史通过标准化问卷回答获得,肝活检样本按NASH临床研究网络标准集中进行组织学评分。
- 采用协变量校正的逻辑回归分析NAFLD严重程度的组织学特征与中度饮酒和/或ADH1B*2之间的关联。
主要发现
- 亚裔/太平洋岛民/夏威夷人中ADH1B*2等位基因携带者比例(86%)高于其他种族组(4%-13%)。
- 研究人群以非西班牙裔白人为主(1153例,74%),主要分析聚焦于该组,其中中度饮酒者433例,ADH1B*2携带者90例。
- 校正包括饮酒状态在内的混杂因素后,与ADH1B*1相比,ADH1B*2与脂肪性肝炎频率降低相关(OR 0.52;P<.01),与纤维化频率降低相关(OR 0.69;P=.050)。
- 中度饮酒(g/d)降低ADH1B*1或ADH1B*2患者的NAFLD严重程度。
- 与ADH1B*1相比,ADH1B*2与明确NASH风险降低相关(ADH1B*2:OR 0.80;P<.01 vs ADH1B*1:OR 0.96;P=.036),并与NAFLD活动度评分≥4的风险降低相关(ADH1B*2:OR 0.83;P=.012 vs ADH1B*1:OR 0.96;P=.048)(两等位基因间中度饮酒效应的差异P<.01)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Alcohol dehydrogenase 1B (ADH1B) is involved in alcohol metabolism. The allele A (ADH1B∗2) of the rs1229984: A>G variant in ADH1B is associated with a higher alcohol metabolizing activity compared to the ancestral allele G (ADH1B∗1). Moderate alcohol consumption is associated with reduced severity of nonalcoholic fatty liver disease (NAFLD), based on histologic analysis, compared with no alcohol consumption. However, it is unclear whether ADH1B∗2 modifies the relationship between moderate alcohol consumption and severity of NAFLD. We examined the association between ADH1B∗2 and moderate alcohol consumption and histologic severity of NAFLD. METHODS: We collected data from 1557 multiethnic adult patients with biopsy-proven NAFLD enrolled into 4 different studies conducted by the Nonalcoholic Steatohepatitis (NASH) Clinical Research Network. Histories of alcohol consumption were obtained from answers to standardized questionnaires. Liver biopsy samples were analyzed by histology and scored centrally according to the NASH Clinical Research Network criteria. We performed covariate adjusted logistic regressions to identify associations between histologic features of NAFLD severity and moderate alcohol consumption and/or ADH1B∗2. RESULTS: A higher proportion of Asians/Pacific Islanders/Hawaiians carried the ADH1B∗2 allele (86%) than other racial groups (4%-13%). However, the study population comprised mostly non-Hispanic whites (1153 patients, 74%), so the primary analysis focused on this group. Among them, 433 were moderate drinkers and 90 were ADH1B∗2 carriers. After we adjusted for confounders, including alcohol consumption status, ADH1B∗2 was associated with lower frequency of steatohepatitis (odds ratio [OR], 0.52; P < .01) or fibrosis (odds ratio, 0.69; P = .050) compared with ADH1B∗1. Moderate alcohol consumption (g/d) reduced the severity of NAFLD in patients with ADH1B∗1 or ADH1B∗2. However, ADH1B∗2, compared to ADH1B∗1, was associated with a reduced risk of definite NASH (ADH1B∗2: OR, 0.80; P < .01 vs ADH1B∗1: OR, 0.96; P = .036) and a reduced risk of an NAFLD activity score of 4 or higher (ADH1B∗2: OR, 0.83; P = .012 vs ADH1B∗1: OR, 0.96; P = .048) (P < .01 for the difference in the effect of moderate alcohol consumption between alleles). The relationship between body mass index and NAFLD severity was significantly modified by ADH1B∗2, even after we controlled for alcohol consumption. CONCLUSIONS: ADH1B∗2 reduces the risk of NASH and fibrosis in adults with NAFLD regardless of alcohol consumption status. ADH1B∗2 might modify the association between high body mass index and NAFLD severity.
引用
- Vilar-Gomez E, Sookoian S, Pirola CJ, et al. ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption. Gastroenterology. 2020. PMID: 32454036. doi:10.1053/j.gastro.2020.05.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。